Form 10-K/A
BIOTIME INC filed this Form 10-K/A on 04/30/2019
Document Outline
Entire Document (837.7 KB)
Subdocument 1 - 10-K/A
Page 1 - UNITED STATES
Page 2 - BioTime, Inc.
Page 3 - EXPLANATORY NOTE
Page 4 - PART III
Page 5 - Neal C. Bradsher, CFA. Mr. Bradsher has been President of Broadwood Capital, Inc., a private investm
Page 6 - Cavan Redmond. Mr. Redmond is a seasoned healthcare strategist, who has held a number of global lead
Page 7 - Gary Hogge, D.V.M., Ph.D. Dr. Hogge joined BioTime as our Senior Vice President of Clinical and Medi
Page 8 - Changes in Stockholder Nomination Procedures
Page 9 - Narrative to Summary Compensation Table
Page 10 - Employment Agreements and Termination of Employment Change in Control Arrangements
Page 11 - Outstanding Equity Awards at Fiscal Year-End
Page 12 - Director Compensation
Page 13 - 2018 DIRECTOR COMPENSATION
Page 14 - ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATT
Page 15 - Equity Compensation Plan Information
Page 16 - ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Page 17 - Related Person Transaction Policy
Page 18 - ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Page 19 - PART IV
Page 20 - SIGNATURES
Page 21 - N/A
Subdocument 2 - EX-23.1 - Consents of experts and counsel
Page 1 - Exhibit 23.1
Page 2 - N/A
Subdocument 3 - EX-31.1 - Certifications required under Section 302 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 31.1
Page 2 - N/A
Subdocument 4 - EX-31.2 - Certifications required under Section 302 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 31.2
Page 2 - N/A
Subdocument 5 - EX-99.2 - Exhibits not specifically designated by another number and by investment companies
Page 1 - Report of Independent Registered Public Accounting Firm
Page 2 - ONCOCYTE CORPORATION
Page 3 - ONCOCYTE CORPORATION
Page 4 - ONCOCYTE CORPORATION
Page 5 - ONCOCYTE CORPORATION
Page 6 - ONCOCYTE CORPORATION
Page 7 - ONCOCYTE CORPORATION
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - 3. Selected Balance Sheet Components
Page 15 - 5. Loan Payable to Silicon Valley Bank
Page 16 - 6. Shareholders Equity
Page 17 - N/A
Page 18 - N/A
Page 19 - 7. Stock-Based Compensation
Page 20 - N/A
Page 21 - N/A
Page 22 - 8. Income Taxes
Page 23 - N/A
Page 24 - 9. Commitments and Contingencies
Page 25 - N/A
Page 26 - 10. Subsequent Events
Page 27 - N/A